UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.83 +0.81 (+1.04%) GOLD FUTURES
2,391.60 +31.70 (+1.34%) DOW
39,859.66 +301.55 (+0.76%) Bitcoin GBP
51,788.36 +3,304.57 (+6.82%)
T2 Biosystems, Inc. (TTOO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 03:21PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 56.33M |
| Enterprise value | 99.62M |
| Trailing P/E | 0.04 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.23 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 13.88 |
| Enterprise value/EBITDA | -0.85 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -84.36% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 70.00 |
| 52-week low 3 | 2.60 |
| 50-day moving average 3 | 3.41 |
| 200-day moving average 3 | 11.53 |
Share statistics
| Avg vol (3-month) 3 | 273.72k |
| Avg vol (10-day) 3 | 598.56k |
| Shares outstanding 5 | 13.54M |
| Implied shares outstanding 6 | 14.29M |
| Float 8 | 4.66M |
| % held by insiders 1 | 2.42% |
| % held by institutions 1 | 70.83% |
| Shares short (30 Apr 2024) 4 | 592.5k |
| Short ratio (30 Apr 2024) 4 | 2.31 |
| Short % of float (30 Apr 2024) 4 | 7.44% |
| Short % of shares outstanding (30 Apr 2024) 4 | 6.74% |
| Shares short (prior month 28 Mar 2024) 4 | 396.91k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:100 |
| Last split date 3 | 13 Oct 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -611.35% |
Management effectiveness
| Return on assets (ttm) | -100.17% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 7.18M |
| Revenue per share (ttm) | 1.86 |
| Quarterly revenue growth (yoy) | -0.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -45.4M |
| Net income avi to common (ttm) | -45.65M |
| Diluted EPS (ttm) | 109.92 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 6.21M |
| Total cash per share (mrq) | 0.71 |
| Total debt (mrq) | 49.5M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.28 |
| Book value per share (mrq) | -6.85 |
Cash flow statement
| Operating cash flow (ttm) | -46.88M |
| Levered free cash flow (ttm) | -30.95M |
© 2024 Yahoo. All rights reserved.